Out now! Updated prescribing tool for type 2 diabetes

An indispensable guide for simplifying treatment in the 'twincretin' era
3
10 January 2024
Save
Please login to bookmark Close

This content has been independently produced by ADG and made possible through sponsorship from Eli Lilly.

Associate Professor Gary Kilov created this updated prescribing guide to help GPs select second—and third-line agents to treat type 2 diabetes.

It includes a new class of agents for adults with T2D – single-agent dual agonists targeting glucose-dependent insulinotropic peptide (GIP) and glucagon-like peptide-1 (GLP-1).

Informed by the latest clinical guidelines and PBS reimbursement criteria, it provides GPs with a choice of directions in a format that is easy to navigate and implement.

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Content that breaches the privacy of other individuals
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .